JAPAN – Tohoku University’s Tohoku Medical Megabank Organization, pharmaceutical companies Daiichi Sankyo and Takeda Pharmaceutical Co., and medical IT firm MICIN have begun a collaborative research project to track long-term…
Read MoreTag: Takeda Pharmaceuticals
Takeda launches Adynovate, a hemophilia drug in India
INDIA – Takeda Pharmaceutical Company Limited has launched Adynovate, an extended half-life recombinant Factor VIII (rFVIII) treatment for hemophilia A patients in India. Adynovate is a novel extended half-life recombinant…
Read MoreDrones to deliver maternal health medicines to rural Benin
BENIN – Drones have been deployed deliver maternal health medicines very quickly to even to remote locations of rural Benin. When the COVID-19 pandemic arrived in Benin on March 16,…
Read MoreSanofi terminates blood disorder gene-editing alliance with Sangamo
FRANCE – Sanofi is terminating a long-running collaboration to develop haemoglobinopathies therapeutics based on Sangamo’s zinc finger nuclease (ZFN) genome-editing technology. Sangamo said in a regulatory filing in the United…
Read MoreBlueprint Medicines expands oncology portfolio by acquiring Lengo Therapeutics for US$465 million
USA – Blueprint Medicines, a US-based biotech that specializes in targeted cancer drugs, is set to pay US$250 million in cash and another US$215 million in potential milestone payments to…
Read MoreDenmark’s Novo Nordisk reaches US$3.3 billion deal to acquire Dicerna Pharma
DENMARK – Novo Nordisk, a Danish pharmaceutical company, has agreed to buy Dicerna Pharmaceuticals for US$3.3 billion in cash, the company has announced. Dicerna Pharmaceuticals creates RNAi-based therapies that selectively…
Read More